Literature DB >> 15702818

Categorization of patients with allergic rhinitis: a comparative profile of "sneezers and runners" and "blockers".

Puneet Khanna1, Ashok Shah.   

Abstract

BACKGROUND: The recent Allergic Rhinitis and Its Impact on Asthma (ARIA) workshop report classified patients into "sneezers and runners" and "blockers" and described a new disease severity categorization.
OBJECTIVE: To sketch the profile of these 2 groups and to evaluate the relevance of categorization.
METHODS: Patients were categorized as "sneezers and runners" (group 1) or "blockers" (group 2). The patients responded to a questionnaire that sought information on symptoms and associated factors. They were then categorized into seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) groups and "intermittent" and "persistent" disease groups and compared.
RESULTS: A total of 114 patients (72 in group 1 and 42 in group 2) participated in the study. The significant features in group 1 were age at onset younger than 20 years (90%); birth date between June and September (61%); family history of atopy (88%); itching of skin (26%), eye (43%), ears (43%), and throat and palate (67%); and aggravation with dust (93%). History of breathlessness (90%), mouth breathing (81%), loss of smell (36%), and prior nasal surgery (31%) were significant in group 2. Significantly more patients in group 1 had SAR (54%) and moderate-severe intermittent disease (60%), whereas group 2 had PAR (81%) and mild persistent (69%) disease (P = .03). Patients classified as having SAR had intermittent disease (40, 83%) (P = .005), and those with PAR had persistent disease (51, 76%) (P < .001). Sixteen patients (24%) classified as having PAR were in the intermittent category, whereas 7 (17%) classified as having SAR were in the persistent category.
CONCLUSIONS: This study demonstrated that the 2 groups had distinct clinical profiles and that it is important to categorize patients, according to the ARIA report, into intermittent and persistent allergic rhinitis groups.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15702818     DOI: 10.1016/S1081-1206(10)61287-2

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  10 in total

1.  Examining the utilization and tolerability of the non-sedating antihistamine levocetirizine in England using prescription-event monitoring data.

Authors:  Deborah Layton; Vicki Osborne; Anna Gilchrist; Saad A W Shakir
Journal:  Drug Saf       Date:  2011-12-01       Impact factor: 5.606

2.  Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England.

Authors:  Deborah Layton; Lynda Wilton; Andrew Boshier; Victoria Cornelius; Scott Harris; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Rhinophototherapy in persistent allergic rhinitis.

Authors:  Zsolt Bella; Ágnes Kiricsi; Éva Dósa-Rácz Viharosné; Attila Dallos; Ádám Perényi; Mária Kiss; Andrea Koreck; Lajos Kemény; József Jóri; László Rovó; Edit Kadocsa
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-18       Impact factor: 2.503

4.  Diode laser treatment in therapy-resistant allergic rhinitis: impact on nasal obstruction and associated symptoms.

Authors:  Philipp P Caffier; Hans Scherer; Konrad Neumann; Sven Lück; Harald Enzmann; Andreas Haisch
Journal:  Lasers Med Sci       Date:  2010-07-10       Impact factor: 3.161

5.  Examining the tolerability of the non-sedating antihistamine desloratadine: a prescription-event monitoring study in England.

Authors:  Deborah Layton; Lynda Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

6.  Impact of allergic rhinitis in school going children.

Authors:  Elias Mir; Chandramani Panjabi; Ashok Shah
Journal:  Asia Pac Allergy       Date:  2012-04-30

7.  Pathophysiological classification of chronic rhinosinusitis.

Authors:  James N Baraniuk; Hilda Maibach
Journal:  Respir Res       Date:  2005-12-19

8.  A survey of clinical features of allergic rhinitis in adults.

Authors:  Franco Frati; Ilaria Dell'Albani; Giovanni Passalacqua; Sergio Bonini; Oliviero Rossi; Gianenrico Senna; Cristoforo Incorvaia
Journal:  Med Sci Monit       Date:  2014-11-04

9.  Traditional Chinese Medicine ZHENG Identification Provides a Novel Stratification Approach in Patients with Allergic Rhinitis.

Authors:  Kai-Li Liang; Rong-San Jiang; Chia-Lin Lee; Pei-Jung Chiang; Jui-Shan Lin; Yi-Chang Su
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-18       Impact factor: 2.629

10.  Clinical characteristics of allergic rhinitis according to allergic rhinitis and its impact on asthma guidelines.

Authors:  Chul Hee Lee; Jeong Hun Jang; Hyun Jong Lee; Ic-Tae Kim; Mu Jin Chu; Chun Dong Kim; Yu-Sung Won; Jeong-Whun Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-12-26       Impact factor: 3.372

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.